Apr 11, 2016 11:00 am UTC| Business
SAN RAMON, Calif., April 11, 2016 -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet parenteral...
Biota Initiates Phase 2a Efficacy Study of BTA585 for the Treatment of RSV Infections
Apr 11, 2016 11:00 am UTC| Business
ATLANTA, April 11, 2016 -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited...
Uranium Resources Finalizes $12 Million Funding Arrangement With Aspire Capital
Apr 11, 2016 11:00 am UTC| Business
CENTENNIAL, Colo., April 11, 2016 -- Uranium Resources, Inc. (Nasdaq:URRE) (ASX:URI), a uranium exploration and development company, announced today it has executed a Purchase Agreement with Aspire Capital Fund, LLC...
Cyclacel Announces Receipt of Nasdaq Extension
Apr 11, 2016 11:00 am UTC| Business
BERKELEY HEIGHTS, N.J., April 11, 2016 -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC), (NASDAQ:CYCCP); (“Cyclacel” or the “Company”) a biopharmaceutical company developing oral therapies that target the various phases...
Pinnacle Entertainment Announces Preliminary 2016 First Quarter Financial Results
Apr 11, 2016 11:00 am UTC| Business
LAS VEGAS, April 11, 2016 -- Pinnacle Entertainment, Inc. (NASDAQ:PNK) today announced preliminary financial results for the first quarter ended March 31, 2016. Preliminary 2016 First Quarter Financial Results Net...
Apr 11, 2016 11:00 am UTC| Business
WALTHAM, Mass., April 11, 2016 -- Syndax Pharmaceuticals, Inc. (Nasdaq:SNDX), a clinical stage biopharmaceutical company focused on developing entinostat in multiple cancer indications, announced today that entinostat...
Apr 11, 2016 11:00 am UTC| Business
Qualified Infectious Disease Product (QIDP) status granted for oral lefamulin formulation Top-line data from LEAP 2 study expected in 2H17 VIENNA, Austria, and KING OF PRUSSIA, Pa., April 11, 2016 -- Nabriva...